Condition
Symptomatic Non-erosive Gastroesophageal Reflux Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Symptomatic Non-erosive Gastroesophageal Reflux Disease clinical trials that are recruiting, in United States. By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Vonoprazan 10 mg vs placebo for episodic heartburn in non-erosive GERD
This trial tests whether taking vonoprazan 10 mg as needed relieves episodic heartburn in adults with symptomatic non-erosive GERD, compared with a placebo, over 24 weeks.
-
Examining the safety of vonoprazan in pregnant women and their babies
This study is testing whether taking vonoprazan during pregnancy is safe for both mothers and their babies by comparing outcomes between those who took the medication and those who didn’t.
Related topics
Quick answers
How many Symptomatic Non-erosive Gastroesophageal Reflux Disease clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.